Omeros | OMER - Passività Correnti





Passività Correnti Cambiamento Data
Adma Biologics USD 69.54M 13.05M 2025-12
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Gilead Sciences USD 11.81B 485M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Immunic USD 30.62M 539K 2025-12
Insmed USD 468.87M 51.66M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 108.79M 11.8M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Rockwell Medical USD 10.95M 259K 2025-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
United Therapeutics USD 599.1M 38.5M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xoma USD 28.3M 6.81M 2025-09